DAVIS STEPHEN 1131146 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-13 | 2023-07-11 | 2023-07-11 to 2023-07-12 | 4 | Davis Stephen | CEO | dsp | 71602.0 | 66.12 | 4.4 | 25.04 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 36695.0
|
162.63 (ACAD) |
| 2023-07-18 | 2023-07-14 | 2023-07-14 | 4 | Davis Stephen | CEO | dsp | 100000.0 | 73.16 | 6.15 | 30.04 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 36695.0 | 162.63 (ACAD) |
| 2023-07-18 | 2023-07-14 | 2023-07-14 | 4 | Davis Stephen | CEO | acq | 100000.0 | 73.16 | 6.15 | 20.77 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 136695.0 | 162.63 (ACAD) |
| 2023-10-06 | 2023-10-05 | 2023-10-05 | 4 | Davis Stephen | CEO | acq | 103999.0 | 73.92 | 6.35 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 140694.0 | 163.73 (ACAD) |
| 2023-10-06 | 2023-10-05 | 2023-10-06 | 4 | Davis Stephen | CEO | dsp | 51563.0 | 36.65 | 3.15 | 21.96 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 89131.0 | 163.73 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-06 | 4 | Davis Stephen | CEO | acq | 9528.0 | 9.5 | 0.58 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 100253.0 | 164.18 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-08 | 4 | Davis Stephen | CEO | dsp | 3732.0 | 3.72 | 0.23 | 29.96 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 96521.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Davis Stephen | CEO | acq | 10946.0 | 10.19 | 0.67 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 107467.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-26 | 4 | Davis Stephen | CEO | dsp | 5577.0 | 5.19 | 0.34 | 24.67 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 101890.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-27 | 4 | Davis Stephen | CEO | dsp | 17714.0 | 12.97 | 1.08 | 17.9 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 118842.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Davis Stephen | CEO | acq | 34666.0 | 25.39 | 2.11 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code A | 136556.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-08 | 4 | Davis Stephen | CEO | dsp | 26574.0 | 15.55 | 1.62 | 17.87 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 144267.0
|
164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 | 4 | Davis Stephen | CEO | acq | 51999.0 | 30.44 | 3.17 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 170841.0
|
164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-02 | 4 | Davis Stephen | CEO | dsp | 11427.0 | 6.86 | 0.7 | 16.94 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 155231.0 | 164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Davis Stephen | CEO | acq | 22391.0 | 13.44 | 1.36 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 166658.0 | 164.18 (ACAD) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-18 | 2023-07-14 | 2023-07-14 | 4 | Davis Stephen | CEO | dsp | 100000.0 | 31.25 | 6.15 | 20.77 | Direct | Stock Option (Right To Buy) | ACADIA PHARMACEUTICALS INC | code M | 220000.0 | 162.63 (ACAD) |
| 2023-10-06 | 2023-10-05 | 2023-10-06 | 4 | Davis Stephen | CEO | dsp | 103999.0 | 37.5 | 6.35 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 173332.0 | 163.73 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-06 | 4 | Davis Stephen | CEO | dsp | 9528.0 | 100.0 | 0.58 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Davis Stephen | CEO | dsp | 10946.0 | 50.0 | 0.67 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 10946.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Davis Stephen | CEO | acq | 286451.0 | 100.0 | 17.45 | 17.84 | Direct | Stock Option (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 286451.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 | 4 | Davis Stephen | CEO | dsp | 51999.0 | 27.27 | 3.17 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 138666.0
|
164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Davis Stephen | CEO | dsp | 22391.0 | 25.0 | 1.36 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 67173.0 | 164.18 (ACAD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)